Top Markets
Coin of the day
Hcmed Hcmed

Hcmed

6934
株式のランク #20836
HCmed Innovations Co Ltd. specializes in creating advanced solutions for... HCmed Innovations Co Ltd. specializes in creating advanced solutions for respiratory treatment through the application of mesh technology. Their product line features devices such as Pulmogine and AdheResp. Beyond its core offerings, the company delivers extensive analytical services focused on aerosol characterization, helping clients optimize and develop new inhaled therapeutic products. This analytical assistance is provided in strict adherence to Pharmacopoeia standards. Founded on October 6, 2014, by Jason Cheng, Leon Tsai, Shaogi Huang, and Simon Hsieh, HCmed maintains its principal office in Taipei, Taiwan.
株価
$3.83
最終同期: 2026-02-24
時価総額
$120.91M
変化(1日)
2.55%
変化(1年)
80.49%
TW
取引 Hcmed (6934)

カテゴリー

Hcmed(6934)の配当利回りの履歴
Hcmed(銘柄コード: 6934)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Hcmed(6934)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)